Jaume Capdevila
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Oncology top 10%
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 33
- Oncology 8
- Cancer-related Molecular Pathways 7
- Co-authors
- Enrique Grande (10 shared papers)Neda Stjepanovic (1 shared paper)Bruce Robinson (7 shared papers)Steven I. Sherman (5 shared papers)Marcia S. Brose (7 shared papers)Ana O. Hoff (4 shared papers)Barbara Jarząb (4 shared papers)Martin Jean Schlumberger (5 shared papers)
- Journals
- Thyroid (4 papers)Cancer Treatment Reviews (2 papers)Cancer (2 papers)Endocrine Related Cancer (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Jaume Capdevila
33 papers receiving 1.4k citations
Jaume Capdevila's Hit Papers
Peers
Comparison fields: 5 of 69
- Endocrinology, Diabetes and Metabolism 1.0k
- Oncology 338
- Anatomy 9
- Genetics 171
- Pulmonary and Respiratory Medicine 161
Countries citing papers authored by Jaume Capdevila
This map shows the geographic impact of Jaume Capdevila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaume Capdevila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaume Capdevila more than expected).
Fields of papers citing papers by Jaume Capdevila
This network shows the impact of papers produced by Jaume Capdevila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaume Capdevila. The network helps show where Jaume Capdevila may publish in the future.
Co-authors
The 25 scholars most cited alongside Jaume Capdevila, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD-1 Blockade in Anaplastic Thyroid Carcinoma Hit paper breakdown → | 2020 | 261 |
| 2 | Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2021 | 187 |
| 3 | Phase 3 Trial of Selpercatinib in Advanced RET -Mutant Medullary Thyroid Cancer Hit paper breakdown → | 2023 | 122 |
| 4 | 2012 | 99 | |
| 5 | 2014 | 74 | |
| 6 | 2016 | 71 | |
| 7 | 2016 | 66 | |
| 8 | 2012 | 57 | |
| 9 | 2013 | 55 | |
| 10 | 2022 | 54 | |
| 11 | 2012 | 51 | |
| 12 | 2022 | 46 | |
| 13 | 2023 | 43 | |
| 14 | 2018 | 36 | |
| 15 | 2021 | 36 | |
| 16 | 2017 | 31 | |
| 17 | 2022 | 28 | |
| 18 | 2015 | 20 | |
| 19 | A significant response to sunitinib in a patient with anaplastic thyroid carcinoma. | 2013 | 18 |
| 20 | 2022 | 13 |
About Jaume Capdevila
Jaume Capdevila is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Genetics, having authored 33 papers that have together received 1.5k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (33 papers), Cancer-related Molecular Pathways (7 papers), BRCA gene mutations in cancer (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer Genomics and Diagnostics (1 paper) and Biomarkers in Disease Mechanisms (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.0k citations), Oncology (338 citations), Anatomy (9 citations), Genetics (171 citations) and Pulmonary and Respiratory Medicine (161 citations). Jaume Capdevila has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Enrique Grande, Neda Stjepanovic, Bruce Robinson, Steven I. Sherman, Marcia S. Brose, Ana O. Hoff, Barbara Jarząb, Martin Jean Schlumberger, Fernanda Vaisman and Erika Hitre. Their work appears in journals such as Thyroid, Cancer Treatment Reviews, Cancer, Endocrine Related Cancer and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.